Total Payments
$5,953
2024 Payments
$1,249
Companies
33
Transactions
223
Medicare Patients
2,295
Medicare Billing
$662,004
Payment Breakdown by Category
Food & Beverage$5,953 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,953 | 223 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,032 | 34 | $0 (2024) |
| Horizon Therapeutics plc | $538.09 | 19 | $0 (2023) |
| Amgen Inc. | $369.88 | 17 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $348.72 | 12 | $0 (2024) |
| Baxter Healthcare | $338.38 | 2 | $0 (2022) |
| OPKO Pharmaceuticals, LLC | $326.82 | 25 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $311.14 | 6 | $0 (2024) |
| Relypsa, Inc. | $289.84 | 9 | $0 (2020) |
| Bayer Healthcare Pharmaceuticals Inc. | $281.93 | 14 | $0 (2023) |
| Vifor Pharma, Inc. | $254.93 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,249 | 48 | Amgen Inc. ($304.97) |
| 2023 | $1,222 | 46 | AstraZeneca Pharmaceuticals LP ($250.70) |
| 2022 | $816.18 | 29 | Horizon Therapeutics plc ($195.09) |
| 2021 | $415.01 | 22 | AstraZeneca Pharmaceuticals LP ($93.65) |
| 2020 | $497.26 | 22 | Otsuka America Pharmaceutical, Inc. ($146.12) |
| 2019 | $1,267 | 46 | AstraZeneca Pharmaceuticals LP ($323.67) |
| 2018 | $486.78 | 10 | Relypsa, Inc. ($147.72) |
All Payment Transactions
223 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $28.85 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: DIABETES | ||||||
| 11/26/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $26.20 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/20/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Nephrology | ||||||
| 11/15/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $28.25 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/23/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: NEPHROLOGY | ||||||
| 10/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: DIABETES | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $29.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/17/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $27.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/12/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $30.26 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/05/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: IMMUNOLOGY | ||||||
| 09/04/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/03/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Inflammation | ||||||
| 08/28/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $25.85 | General |
| Category: NEPHROLOGY | ||||||
| 08/20/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: IMMUNOLOGY | ||||||
| 08/14/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $31.18 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/31/2024 | Xeris Pharmaceuticals, Inc. | KEVEYIS (Drug) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: Carbonic anhydrase inhibitor | ||||||
| 07/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Diabetes | ||||||
| 07/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: DIABETES | ||||||
| 06/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 575 | 1,594 | $441,339 | $144,395 |
| 2022 | 10 | 411 | 1,019 | $383,846 | $134,467 |
| 2021 | 11 | 570 | 1,359 | $472,814 | $163,899 |
| 2020 | 12 | 739 | 1,853 | $700,293 | $219,242 |
Total Patients
2,295
Total Services
5,825
Medicare Billing
$662,004
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 27 | 153 | $129,429 | $44,536 | 34.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 93 | 314 | $60,803 | $19,738 | 32.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 94 | 184 | $57,182 | $16,986 | 29.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 66 | 135 | $39,190 | $12,766 | 32.6% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 17 | 44 | $29,983 | $10,608 | 35.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 59 | 72 | $31,352 | $9,924 | 31.7% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 38 | 255 | $24,863 | $8,037 | 32.3% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 38 | 173 | $20,760 | $6,740 | 32.5% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 34 | 119 | $14,676 | $4,755 | 32.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 27 | $11,805 | $3,724 | 31.5% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 33 | 65 | $11,474 | $3,688 | 32.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $8,256 | $2,400 | 29.1% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 33 | 33 | $1,568 | $492.48 | 31.4% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 39 | 223 | $161,586 | $64,926 | 40.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 83 | 294 | $54,543 | $16,760 | 30.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 78 | 175 | $48,487 | $15,695 | 32.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 64 | 124 | $33,011 | $10,158 | 30.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 51 | 55 | $33,990 | $8,693 | 25.6% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 24 | 32 | $19,502 | $7,590 | 38.9% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 27 | 66 | $12,342 | $3,872 | 31.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 23 | 26 | $9,646 | $3,257 | 33.8% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 11 | 13 | $6,128 | $2,166 | 35.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $4,610 | $1,350 | 29.3% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 32 | 166 | $120,370 | $48,857 | 40.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 129 | 443 | $82,185 | $25,642 | 31.2% |
About Dr. Ajay Kallam, MD
Dr. Ajay Kallam, MD is a Nephrology healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/20/2008. The National Provider Identifier (NPI) number assigned to this provider is 1306003124.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ajay Kallam, MD has received a total of $5,953 in payments from pharmaceutical and medical device companies, with $1,249 received in 2024. These payments were reported across 223 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($5,953).
As a Medicare-enrolled provider, Kallam has provided services to 2,295 Medicare beneficiaries, totaling 5,825 services with total Medicare billing of $662,004. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Dallas, TX
- Active Since 05/20/2008
- Last Updated 06/20/2018
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1306003124
Products in Payments
- KRYSTEXXA (Biological) $807.82
- LOKELMA (Drug) $679.29
- Veltassa (Drug) $544.77
- FARXIGA (Drug) $353.06
- JYNARQUE (Drug) $348.72
- Renal - PD (Device) $338.38
- LUPKYNIS (Drug) $311.14
- ACTHAR (Biological) $295.78
- Kerendia (Drug) $281.93
- JARDIANCE (Drug) $277.07
- RAYALDEE (Drug) $187.87
- AURYXIA (Drug) $160.01
- TARPEYO (Drug) $141.07
- Rayaldee (Drug) $138.95
- ZEPATIER (Drug) $137.69
- Velphoro (Drug) $137.66
- BENLYSTA (Biological) $121.50
- JESDUVROQ (Drug) $116.20
- Auryxia (Drug) $68.86
- Parsabiv (Drug) $64.91
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Dallas
Dr. Ankit Mehta, M.d, M.D
Nephrology — Payments: $907,733
Nephrology $907,733
Irfan Agha, M.d, M.D
Nephrology — Payments: $278,709
Nephrology $278,709
Robert Toto, Md, MD
Nephrology — Payments: $199,974
Nephrology $199,974
Russell Silverstein, M.d, M.D
Nephrology — Payments: $190,316
Nephrology $190,316
Christopher Hebert, Md, MD
Nephrology — Payments: $174,262
Nephrology $174,262
Dr. Sumit Kumar, M.d, M.D
Nephrology — Payments: $158,458
Nephrology $158,458